Form 4: Ameresco Director Claire D'Oyly-Hughes Johnson Receives Stock Grant
SEC Form 4 Filing
Director Claire D'Oyly-Hughes Johnson received a grant of 4,886 Restricted Stock Units (RSUs) from Ameresco, Inc. on June 4, 2024, according to a Form 4 filing.
Summary
- On June 4, 2024, Claire D'Oyly-Hughes Johnson, a director of Ameresco, Inc., was granted 4,886 Restricted Stock Units (RSUs).
- Each RSU represents a contingent right to receive one share of Ameresco, Inc. Class A Common Stock.
- The RSUs will vest in full on June 4, 2025, provided the director continues service through the vesting date.
- The transaction was reported on June 6, 2024, in a Form 4 filing with the SEC.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. It reflects standard compensation practice, aligning director interests with shareholders. No negative information is present.
Positives
- The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.
Future Outlook
The director's continued service is implied by the vesting conditions of the RSU grant.
Industry Context
Stock grants are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders.
Stakeholder Impact
- The RSU grant aligns the director's interests with those of the shareholders.
- The grant incentivizes the director to contribute to the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of RSU grant |
| 06/04/2025 | Vesting date of the RSUs |
| 06/06/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.